Endogenous retroviruses are a source of enhancers with oncogenic potential in acute myeloid leukaemia

Autor: Ana Rio-Machin, Özgen Deniz, Miguel R. Branco, Mark A. Dawson, Christopher D. Todd, Mamataz Ahmed
Rok vydání: 2020
Předmět:
0301 basic medicine
Tumour heterogeneity
Science
Transcriptional regulatory elements
General Physics and Astronomy
Endogenous retrovirus
Biology
General Biochemistry
Genetics and Molecular Biology

Article
Acute myeloid leukaemia
Cell Line
Epigenesis
Genetic

03 medical and health sciences
0302 clinical medicine
hemic and lymphatic diseases
Animals
Humans
Gene Regulatory Networks
Epigenetics
lcsh:Science
Enhancer
Gene
Transcription factor
030304 developmental biology
Epigenomics
Regulation of gene expression
0303 health sciences
Multidisciplinary
Genome
Human

Endogenous Retroviruses
Myeloid leukemia
Interspersed repetitive sequences
General Chemistry
Pediatric cancer
Chromatin
3. Good health
Cell biology
Leukemia
Myeloid
Acute

030104 developmental biology
030220 oncology & carcinogenesis
DNA Transposable Elements
lcsh:Q
Zdroj: Nature Communications
Nature Communications, Vol 11, Iss 1, Pp 1-14 (2020)
ISSN: 2041-1723
Popis: Acute myeloid leukemia (AML) is characterised by a series of genetic and epigenetic alterations that result in deregulation of transcriptional networks. One understudied source of transcriptional regulators are transposable elements (TEs), whose aberrant usage could contribute to oncogenic transcriptional circuits. However, the regulatory influence of TEs and their links to AML pathogenesis remain unexplored. Here we identify six endogenous retrovirus (ERV) families with AML-associated enhancer chromatin signatures that are enriched in binding of key regulators of hematopoiesis and AML pathogenesis. Using both locus-specific genetic editing and simultaneous epigenetic silencing of multiple ERVs, we demonstrate that ERV deregulation directly alters the expression of adjacent genes in AML. Strikingly, deletion or epigenetic silencing of an ERV-derived enhancer suppresses cell growth by inducing apoptosis in leukemia cell lines. This work reveals that ERVs are a previously unappreciated source of AML enhancers that may be exploited by cancer cells to help drive tumour heterogeneity and evolution.
Transposable elements are a potential source of transcriptional regulators, but how these sequences contribute to oncogenesis remains poorly understood. Here, the authors identify endogenous retroviruses (ERVs) with acute myeloid leukemia (AML)-associated enhancer chromatin signatures, and provide evidence that ERV activation provides an additional layer of gene regulation in AML.
Databáze: OpenAIRE